When: May 21-26, 2018 (with online activities to be held before and after)
How: Apply online until January 15, 2018 at 23h59 EST. APPLICATION PERIOD NOW CLOSED
Who: Open to graduate students and early career researchers who want to develop and extend their knowledge about behavioural trials
Notez bien: Ce programme est offert uniquement en anglais.
About the Inaugural IBTN Summer School
The Inaugural IBTN Summer School is an academic program held over 6 days exploring how to breakthrough current obstacles in behavioural trial methodologies and expand the reach, capacity, and impact of trials in the field of behavioural medicine.
Participants will learn about developing effective behavioural interventions and conducting high-quality trials through interactive workshops and training activities. Central to the program will be participants’ attendance to the concurrent activities of the IBTN 2018 Conference.
Working with internationally renowned experts in innovative clinical trials, behavioural intervention development, and patient-oriented research, students will attend courses and workshops from May 21 to 24, then conference activities, including plenaries, workshops, public lectures, and poster sessions, from May 24 to 26.
Both program segments are designed to foster networking opportunities to its participants, and will include additional online activities prior to and after the on-site program.
The Summer School initiative will be offered yearly over the next five years by the International Behavioural Trials Network (IBTN) Chair through Concordia University with the support of the Canadian Institutes of Health Research’s Strategy for Patient-Oriented Research (CIHR SPOR), Université du Québec à Montréal (UQAM), the UQAM Chair in Behavioural Medicine, the Centre intégré universitaire de santé et de services sociaux du Nord-de-l’Île-de-Montréal (CIUSS-NIM), and the Montréal Behavioural Medicine Centre (MBMC).
- May 21: Opening dinner
- May 22: Courses
- May 23: Courses
- May 24: Courses + IBTN Conference opening cocktail and poster presentations
- May 25: IBTN Conference and dinner event
- May 26: IBTN Conference and public lectures
View the provisional course outline (PDF)
Angela Alberga, PhD (Concordia University)
Assistant Professor in the Department of Exercise Science at Concordia University. She was awarded an Eyes High Postdoctoral Fellowship and a Banting Canadian Institutes of Health Research (CIHR) Postdoctoral Fellowship at the University of Calgary supporting her research on weight stigma reduction in education, healthcare and public policy. She was awarded a Canadian Diabetes Association Doctoral Research Award for her research focused on improving the cardiometabolic health of children and adolescents with obesity through exercise.
Simon Bacon, PhD (Concordia University)
Professor in the Department of Exercise Science at Concordia University, Canadian Institutes of Health Research (CIHR) Strategy for Patient-Oriented Research (SPOR) Chair in Innovative, Patient-Oriented, Behavioural Clinical Trials, Co-Director of the Montréal Behavioural Medicine Centre, fellow of the Obesity Society and the Canadian Cardiovascular Society, and researcher at the Centre intégré universitaire de santé et service sociaux du nord de l’île de Montréal (CIUSSS-NIM) and co-lead of the International Behavioural Trials Network.
Molly Byrne, PhD (National University of Ireland, Galway)
Professor of Health Psychology at the National University of Ireland, Galway and recipient of the Health Research Board (HRB, Ireland) Research Leadership Award (2014-2019) to establish and direct the Health Behaviour Change Research Group (HBCRG).
Tavis Campbell, PhD (University of Calgary)
Professor of Clinical Psychology and Oncology at the University of Calgary, where he also holds the position of Director of Clinical training. He has published results from several behavior-based RCTs in the areas of cancer, pain, and chronic disease management, including the i-can sleep trial targeting insomnia in cancer survivors. He is actively involved in the Canadian Hypertension Education Program (CHEP) and is Chair of the Adherence Committee and an active member of the Knowledge Translation Committee at Hypertension Canada.
Kim Lavoie, PhD (University du Québec à Montréal)
Co-Director of the Montréal Behavioural Medicine Centre, co-lead of the International Behavioural Trials Network (IBTN) and former Director of the Chronic Disease Research Division at Hôpital du Sacré-Coeur de Montréal. She is a Full Professor in the Department of Psychology and Chair of Behavioral Medicine at the Université du Québec à Montréal. She is also Chair of Health Psychology and Behavioural Medicine at the Canadian Psychological Association and an active member of the CHEP recommendation panel (Adherence Subcommittee). She currently holds a Quebec Health Research (FRQS) Senior Investigator Award.
Justin Presseau, PhD (University of Ottawa)
Scientist and health psychologist at the Ottawa Hospital Research Institute and Assistant Professor in the School of Epidemiology, Public Health and Preventive Medicine at the University of Ottawa. He holds a Ph.D. in Psychology from the University of Aberdeen (UK). His research draws upon theories and approaches from health psychology and behavioural medicine to develop and evaluate interventions focused on changing healthcare professional behaviours and health behaviours of patients and the public.
Paul Montgomery, PhD (University of Birmingham)
Professor of Social Interventions, and leads on the development of the CONSORT-SPI, a reporting guideline for randomised trials of complex psychological and social interventions. His academic work spans a range of issues, from chronic sleep problems to HIV/AIDS, and integrates the use of several high-quality methodological approaches. He specialises in Brief Intervention and Cognitive Behavioural techniques for depression, anxiety and insomnia. His work falls under three broad categories: Methodology of Psycho-Social Intervention, Nutrition, and Behavioural Interventions.
Key program workshops
Jean Bourbeau, MD (McGill University)
Respirologist and Professor in the Department of Medicine and Epidemiology & Biostatistics at McGill University, and director of the McConnell Centre of Innovative Medicine (CIM) of the Research Institute of the MUHC (RIMUHC) and the Pulmonary Rehabilitation Unit at the Montreal Chest Institute of the McGill University Health Centre (MUHC). He also chairs the COPD axis of the Health Respiratory Network of the FRQS (Fonds de recherche du Québec – Santé), past president and current member of the Canadian Thoracic Society, and sits on the scientific committee of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) and leading/co-leading Guidelines/Position statements in COPD (CTS, Chest, ATS/ERS, and GOLD).
David Buckeridge, PhD (McGill University)
Associate Professor of Epidemiology and Biostatistics at McGill University where he holds a Canadian Institutes of Health Research Chair in e-Health Interventions. He is also a Medical Consultant to the Montreal Public Health Department and the Quebec Public Health Institute.
Linda Collins, PhD (Pennsylvania State University)
Director of Pennsylvania State University’s The Methodology Center, Distinguished Professor in the Department of Human Development and Family Studies and Professor in the Department of Statistics.
Susan Czajkowski, PhD (National Institutes of Health)
Chief of the Health Behaviors Research Branch (HBRB) of the National Cancer Institute (NCI) and previously project officer for the Enhancing Recovery in Coronary Heart Disease (ENRICHD) Patients Study and lead project officer for the NIH-funded Obesity-Related Behavioral Intervention Trials (ORBIT) network. She is also a fellow in the Society of Behavioral Medicine, and recently served as President of the Academy of Behavioral Medicine Research.
Ken Freedland, PhD (Washington University)
Professor of Psychiatry and Psychology at Washington University School of Medicine and co-investigator and clinical supervisor for the multicenter Enhancing Recovery in Coronary Heart Disease (ENRICHD), a co-investigator and assessment core leader for the multicenter CODIACS Vanguard trial, and a co-investigator and clinical supervisor for the multicenter INSPIRE trial of stress management for lung transplant candidates. He is also a founding fellow of the Academy of Cognitive Therapy (ACT) and an ACT-certified cognitive therapy trainer, an instructor in clinical trial methodology on the faculty of the National Institutes of Health annual Summer Institute on Randomized Behavioural Clinical Trials.
Susan Michie, PhD (University College London)
Professor of Health Psychology at University College London (UCL) and Director of its Centre for Behaviour Change (CBC) and of the Health Psychology Research Group. She leads the Human Behaviour-Change Project, holds an NIHR Senior Investigator’s award, is Associate Editor of Annals of Behavioral Medicine and Fellow of SBM, AcBehMedRes, AcMedSci, AcadSocSci, EHPS and BPS.
Robert West, PhD (University College London)
Professor of Health Psychology at University College London, and Director of Tobacco Studies for the Cancer Research UK Health Behaviour Unit in the Department of Epidemiology and Public Health at University College London.
Simon L. Bacon, Ph.D., FTOS, FCCS
- CIHR SPOR Chair in Innovative, Patient-Oriented, Behavioural Clinical Trials
- Full Professor, Department of Exercise Science, Concordia University
- Co-director, Montréal Behavioural Medicine Centre (MBMC), CIUSSS-NIM